The combination of Astragalus membranaceus and ligustrazine mitigates cerebral ischemia‐reperfusion injury via regulating NR2B‐ERK/CREB signaling
Brain and Behavior · 2023-02 · 13 (2)
DOI: 10.1002/brb3.2867 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 31.12.2022. Verfasst von Xialing Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China. Hauptthemen laut MEDLINE: Brain Ischemia, Reperfusion Injury, Neuroprotective Agents. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation and Strong University Project of Guangzhou University of Traditional Chinese Medicine, National Natural Science Foundation of China, Guangdong Provincial Key Laboratory of Chinese Medicine on Emergency in Traditional Chinese Medicine.
Abstract (Originalsprache)
Background and purpose Cerebral ischemia‐reperfusion (I/R) injury is a major factor underlying the high mortality and morbidity rates in stroke patients. Our previous study found that the combination of Astragalus membranaceus extract and ligustrazine (Ast+Lig) treatment could protect brain tissues against inflammation in rats with thrombolytic cerebral ischemia. Activation of N‐methyl‐D‐aspartate receptors (NMDAR) is implicated in brain damage induced by cerebral I/R injury.
Methods
We used in vivo and in vitro models of cerebral I/R injury for middle cerebral artery occlusion/reperfusion in mice and oxygen‐glucose deprivation/reoxygenation in primary rat cerebral cortical neurons to evaluate the protective effects of Ast+Lig on cerebral I/R injury, and whether the protective mechanism was related to the regulation of NMDAR‐ERK/CREB signaling.
Results
Treatment with Ast+Lig, or MK‐801 (an inhibitor of NMDAR) significantly ameliorated neurological deficits, decreased infarct volumes, suppressed neuronal damage and Ca 2+ influx, and maintained the mitochondrial membrane potential in vivo and in vitro following cerebral I/R injury based on 2,3,5‐triphenyl tetrazolium chloride staining, immunohistochemistry, and immunofluorescent staining. Furthermore, treatment with Ast+Lig evidently prevented the upregulation of NR2B, but not NR2A, in vivo and in vitro following cerebral I/R injury based on western blotting and reverse transcription‐quantitative PCR analyses. Moreover, treatment with Ast+Lig significantly increased the phosphorylation of ERK and CREB, as well as increasing their mRNA expression levels in vivo and in vitro following cerebral I/R injury.
Conclusions
The overall results thus suggest that the Ast+Lig combination conferred neuroprotective properties against cerebral I/R injury via regulation of the NR2B‐ERK/CREB signaling pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Institute of Clinical Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China.
- Diagnosis and Treatment Center of Encephalopathy, Hubei Provincial Hospital of Chinese Medicine, Wuhan, China.
- Diagnosis and Treatment Center of Encephalopathy, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
- Department of Neurosurgery, Hospital of Guangzhou University Mega Center, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China.
ORCID-Profile: Jun Cai
Förderung
- Innovation and Strong University Project of Guangzhou University of Traditional Chinese Medicine
- National Natural Science Foundation of China
- Guangdong Provincial Key Laboratory of Chinese Medicine on Emergency in Traditional Chinese Medicine
- Guangdong Provincial Key Laboratory of Chinese Medicine on Prevention and Treatment of Refractory Chronic Diseases
- Project of Administration of Traditional Chinese Medicine of Guangdong Province of China
Zitieren
APA
Tang, X., Xie, S., Wang, H., Li, Y., Lai, Z., Sun, S., Pan, R., Huang, Y., & Cai, J. (2023). The combination of Astragalus membranaceus and ligustrazine mitigates cerebral ischemia‐reperfusion injury via regulating NR2B‐ERK/CREB signaling. Brain and Behavior, 13(2). https://doi.org/10.1002/brb3.2867
Vancouver
Tang X, Xie S, Wang H, Li Y, Lai Z, Sun S, et al. The combination of Astragalus membranaceus and ligustrazine mitigates cerebral ischemia‐reperfusion injury via regulating NR2B‐ERK/CREB signaling. Brain and Behavior. 2023;13(2). doi:10.1002/brb3.2867
BibTeX
@article{Tang2023,
author = {Tang, Xialing and Xie, Shanshan and Wang, Huajun and Li, Yingbin and Lai, Zhiyu and Sun, Shuangxi and Pan, Ruanhuan and Huang, Yan and Cai, Jun},
title = {The combination of Astragalus membranaceus and ligustrazine mitigates cerebral ischemia‐reperfusion injury via regulating NR2B‐ERK/CREB signaling},
journal = {Brain and Behavior},
year = {2023},
volume = {13},
number = {2},
doi = {10.1002/brb3.2867}
}
EUVIMED